Učitavanje...
Metformin inhibits ovarian cancer growth and increases sensitivity to paclitaxel in mouse models
OBJECTIVE: There is increasing pre-clinical evidence indicating that metformin, a medication commonly used for type 2 diabetes, may protect against cancer. Motivated by this emerging evidence we asked two questions: (a) can metformin prevent ovarian cancer growth by altering metabolism, and (b) will...
Spremljeno u:
| Izdano u: | Am J Obstet Gynecol |
|---|---|
| Glavni autori: | , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2014
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4387077/ https://ncbi.nlm.nih.gov/pubmed/25446664 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajog.2014.10.026 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|